The Burden of Cardiovascular Disease in Low- and Middle-Income Countries: Epidemiology and Management

Canadian Journal of Cardiology

Volumn 31, Issue 9, 2015, Pages 1151-1159

  Bowry, Ashna D K ^b   Lewey, Jennifer ^a,c   Dugani, Sagar B ^a   Choudhry, Niteesh K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; DEVELOPING COUNTRY; DIABETES MELLITUS; DIET; FEMALE; HEALTH CARE ACCESS; HEALTH PROGRAM; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIFESTYLE MODIFICATION; MALE; MORTALITY; OBESITY; PHYSICAL ACTIVITY; REVIEW; RISK FACTOR; TOBACCO USE; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COST OF ILLNESS; DISEASE MANAGEMENT; HEALTH CARE DELIVERY; HYPERLIPIDEMIAS; LIFESTYLE; NEOPLASMS; POVERTY; RESPIRATORY TRACT DISEASES; SMOKING;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COST OF ILLNESS; DIABETES MELLITUS; DISEASE MANAGEMENT; HEALTH SERVICES ACCESSIBILITY; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; LIFE STYLE; NEOPLASMS; POVERTY; RESPIRATORY TRACT DISEASES; RISK FACTORS; SMOKING;

EID: 84940764336     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2015.06.028     Document Type: Review

References (90)

1. Bovet P., Paccaud F. Cardiovascular disease and the changing face of global public health: a focus on low and middle income countries. Public Health Rev 2012, 33:397-415.
2. World Health Orgnaization The World Health Report 2003: Shaping the Future 2003, World Health Organization, Geneva, Available at:, Accessed April 19, 2015. http://www.who.int/whr/2003/en/whr03_en.pdf?ua=1.
3. World Health Organization. Burden: mortality, morbidity and risk factors. In Alwan A, ed. Global Status Report on Noncommunicable Diseases 2010. Geneva: World Health Organization, 2011.
4. Institute for Health Metrics and Evaluation (IHME), GBD database. Availabel at:. Accessed January 10, 2015. http://www.healthdata.org/search-gbd-data.
5. World Health Organization. Definition of region groupings. Health statistics and information systems 2015. Available at:. Accessed April 19, 2015. http://www.who.int/healthinfo/global_burden_disease/definition_regions/en/.
6. GBD 2013 Mortality and Causes of Death Collaborators Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 385:117-171.
7. Lim S.S., Vos T., Flaxman A.D., et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2224-2260.
8. Dasgupta K., Padwal R., Poirier L., Quinn R.R. Managing hypertension: evidence supporting the 2013/2014 recommendations of the Canadian Hypertension Education Program. CMAJ 2015, 187:116-119.
9. Robitaille C., Dai S., Waters C., et al. Diagnosed hypertension in Canada: incidence, prevalence and associated mortality. CMAJ 2012, 184:E49-56.
10. Joffres M., Falaschetti E., Gillespie C., et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open 2013, 3:e003423.
11. Danaei G., Finucane M.M., Lin J.K., et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 2011, 377:568-577.
12. Lloyd-Sherlock P., Beard J., Minicuci N., Ebrahim S., Chatterji S. Hypertension among older adults in low- and middle-income countries: prevalence, awareness and control. Int J Epidemiol 2014, 43:116-128.
13. Kearney P.M., Whelton M., Reynolds K., et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-223.
14. Farzadfar F., Finucane M.M., Danaei G., et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet 2011, 377:578-586.
15. Mozaffarian D., Abdollahi M., Campos H., Houshiarrad A., Willett W.C. Consumption of trans fats and estimated effects on coronary heart disease in Iran. Eur J Clin Nutr 2007, 61:1004-1010.
16. Mendez M.A., Monteiro C.A., Popkin B.M. Overweight exceeds underweight among women in most developing countries. Am J Clin Nutr 2005, 81:714-721.
17. Popkin B.M., Slining M.M. New dynamics in global obesity facing low- and middle-income countries. Obes Rev 2013, 14(suppl 2):11-20.
18. Popkin B.M., Gordon-Larsen P. The nutrition transition: worldwide obesity dynamics and their determinants. Int J Obes Relat Metab Disord 2004, 28(suppl 3):S2-9.
19. Poskitt E.M. Countries in transition: underweight to obesity non-stop?. Ann Trop Paediatr 2009, 29:1-11.
20. Vorster H.H., Kruger A. Poverty, malnutrition, underdevelopment and CVD: a South African perspective. Cardiovasc J Afr 2007, 18:321-324.
21. Hu F.B., Stampfer M.J., Manson J.E., et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997, 337):1491-1499.
22. Pietinen P., Ascherio A., Korhonen P., et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol 1997, 145:876-887.
23. Ascherio A., Katan M.B., Zock P.L., Stampfer M.J., Willett W.C. Trans fatty acids and coronary heart disease. N Engl J Med 1999, 340:1994-1998.
24. Oomen C.M., Ocke M.C., Feskens E.J., et al. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 2001, 357:746-751.
25. Mozaffarian D., Katan M.B., Ascherio A., Stampfer M.J., Willett W.C. Trans fatty acids and CVD. N Engl J Med 2006, 354:1601-1613.
26. Global atlas on cardiovascular disease prevention and control. Published by the World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization 2011, World Health Organization, Geneva, Available at:, Accessed January 30, 2015. http://whqlibdoc.who.int/publications/2011/9789241564373_eng.pdf?ua=1, S. Mendis, P. Puska, B. Norrving (Eds.).
27. Ghafoorunissa G. Role of trans fatty acids in health and challenges to their reduction in Indian foods. Asia Pac J Clin Nutr 2008, 7(suppl 1):212-215.
28. Jha P., Ranson M.K., Nguyen S.N., Yach D. Estimates of global and regional smoking prevalence in 1995, by age and sex. Am J Public Health 2002, 92:1002-1006.
29. Giovino G.A., Mirza S.A., Samet J.M., et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 2012, 380:668-679.
30. Balbinotto S. The costs of CVD in Brazil: a brief economic comment. Arq Bras Cardiol 2008, 91:198-199.
31. Piano M.R., Benowitz N.L., Fitzgerald G.A., et al. Impact of smokeless tobacco products on CVD: implications for policy, prevention, and treatment: a policy statement from the American Heart Association. Circulation 2010, 122:1520-1544.
32. Pell J., Haw S., Cobbe S., et al. Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med 2008, 359:482-491.
33. Oberg M., Jaakkola M.S., Woodward A., Peruga A., Pruss-Ustun A. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet 2011, 377:139-146.
34. Gupta R., Gupta N., Khedar R.S. Smokeless tobacco and CVD in low and middle income countries. Indian Heart J 2013, 65:369-377.
35. Gaziano T.A. Cardiovascular disease in the developing world and its cost-effective management. Circulation 2005, 112:3547-3553.
36. Gaziano T.A., Bitton A., Anand S., Abrahams-Gessel S., Murphy A. Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol 2010, 35:72-115.
37. Chow C.K., Teo K.K., Rangarajan S., et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013, 310:959-968.
38. Joshi R., Jan S., Wu Y., MacMahon S. Global inequalities in access to cardiovascular health care: our greatest challenge. J Am Coll Cardiol 2008, 52:1817-1825.
39. Choudhry N.K., Dugani S., Shrank W.H., et al. Despite increased use and sales of statins in India, per capita prescription rates remain far below high-income countries. Health Aff (Millwood) 2014, 33:273-282.
40. Mendis S., Lindholm L.H., Mancia G., et al. World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of CVD in low and middle-income countries. J Hypertens 2007, 25:1578-1582.
41. Mendis S., Abegunde D., Yusuf S., et al. WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE). Bull WHO 2005, 83:820-829.
42. Yusuf S., Islam S., Chow C.K., et al. Use of secondary prevention drugs for CVD in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet 2011, 378:1231-1243.
43. Choudhry N.K., Setoguchi S., Levin R., Winkelmayer W.C., Shrank W.H. Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients. Pharmacoepidemiol Drug Saf 2008, 17:1189-1196.
44. Jackevicius C.A., Mamdani M., Tu J.V. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002, 288:462-467.
45. Bowry A.D., Shrank W.H., Lee J.L., Stedman M., Choudhry N.K. A systematic review of adherence to cardiovascular medications in resource-limited settings. J Intern Med 2011, 26:1479-1491.
46. Mills E.J., Nachega J.B., Bangsberg D.R., et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 2006, 3:e438.
47. LeBrun D.G., Chackungal S., Chao T.E., et al. Prioritizing essential surgery and safe anesthesia for the Post-2015 Development Agenda: operative capacities of 78 district hospitals in 7 low- and middle-income countries. Surgery 2014, 155:365-373.
48. Xavier D., Pais P., Devereaux P.J., et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet 2008, 371:1435-1442.
49. Powles J., Fahimi S., Micha R., et al. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open 2013, 3:e003733.
50. He F.J., Li J., Macgregor G.A. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2013, 4:CD004937.
51. Aburto N.J., Ziolkovska A., Hooper L., et al. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ 2013, 346:f1326.
52. Morrison A.C., Ness R.B. Sodium intake and CVD. Annu Rev Public Health 2011, 32:71-90.
53. Lee I.M., Shiroma E.J., Lobelo F., et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 2012, 380:219-229.
54. Lear S.A., Teo K., Gasevic D., et al. The association between ownership of common household devices and obesity and diabetes in high, middle and low income countries. CMAJ 2014, 186:258-266.
55. Teo K., Lear S., Islam S., et al. Prevalence of a healthy lifestyle among individuals with CVD in high-, middle- and low-income countries: the Prospective Urban Rural Epidemiology (PURE) study. JAMA 2013, 309:1613-1621.
56. Popkin B. Will China's nutrition transition overwhelm its health care system and slow economic growth?. Health Aff (Millwood) 2008, 27:1064-1076.
57. Franco M., Ordunez P., Caballero B., et al. Impact of energy intake, physical activity, and population-wide weight loss on CVD and diabetes mortality in Cuba, 1980-2005. Am J Epidemiol 2007, 166:1374-1380.
58. Garcia-Ortiz L., Recio-Rodriguez J.I., Schmidt-Trucksass A., et al. Relationship between objectively measured physical activity and cardiovascular aging in the general population-the EVIDENT trial. Atherosclerosis 2014, 233:434-440.
59. Naci H., Ioannidis J.P. Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study. BMJ 2013, 347:f5577.
60. Millett C., Agrawal S., Sullivan R., et al. Associations between active travel to work and overweight, hypertension, and diabetes in India: a cross-sectional study. PLoS Med 2013, 10:e1001459.
61. Steyn K., Damasceno A. Lifestyle and related risk factors for chronic diseases. Disease and Mortality in Sub-Saharan Africa. 2nd edition 2006, World Bank, Washington, DC. 2nd ed. D. Jamison, R.G. Feachem, M.W. Makgoba (Eds.).
62. Samb B., Desai N., Nishtar S., et al. Prevention and management of chronic disease: a litmus test for health-systems strengthening in low-income and middle-income countries. Lancet 2010, 376:1785-1797.
63. IOM (Institute of Medicine) Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health 2010, Washington, DC: National Academies Press,.
64. Gaziano T.A., Steyn K., Cohen D.J., Weinstein M.C., Opie L.H. Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk vs blood pressure level. Circulation 2005, 112:3569-3576.
65. Shillcutt S.D., Walker D.G., Goodman C.A., Mills A.J. Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules. PharmacoEconomics 2009, 27:903-917.
66. National Institute for Health and Clinical Excellence Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34. NICE Clinical Guidelines, No. 127 2011, Royal College of Physicians (UK) National Clinical Guideline Centre (UK), London.
67. Stone N.J., Robinson J.G., Lichtenstein A.H., et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014, 129(25 suppl 2):S1-45.
68. Gaziano T.A., Opie L.H., Weinstein M.C. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 2006, 368:679-686.
69. Jha P., Chaloupka F.J., Moore J.E.A., et al. Tobacco addiction. Disease Control Priorities in Developing Countries 2006, World Bank, Washington DC. 2nd ed. D.T. Jamison, J.G. Breman, A.R. Measham (Eds.).
70. Puska P., Vartiainen E., Laatinkainen T., Jousilahti P., Paavola M. The North Karelia project: From North Karelia to National Action 2009, Helsinki University Printing House, Helsinki.
71. Uusitalo U., Feskens E.J., Tuomilehto J., et al. Fall in total cholesterol concentration over five years in association with changes in fatty acid composition of cooking oil in Mauritius: cross sectional survey. BMJ 1996, 313:1044-1046.
72. Castellano J.M., Sanz G., Penalvo J.L., et al. A polypill strategy to improve adherence: results from the FOCUS project. J Am Coll Cardiol 2014, 64:2071-2082.
73. Castellano J.M., Sanz G., Fernandez Ortiz A., et al. A polypill strategy to improve global secondary cardiovascular prevention: from concept to reality. J Am Coll Cardiol 2014, 64:613-621.
74. Ostovaneh MR, Poustchi H, Hemming K, et al. Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial [Epub ahead of print]. Eur J Prev Cardiol 2014, accessed August 7, 2015.
75. ClinicalTrials.gov. Heart Outcomes Prevention Evaluation-3 (HOPE-3). Available at:. Accessed January 15, 2015. http://clinicaltrials.gov/show/NCT00468923.
76. Selak V., Elley C.R., Bullen C., et al. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of CVD: randomised controlled trial in primary care. BMJ 2014, 348:g3318.
77. Thom S., Poulter N., Field J., et al. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. JAMA 2013, 310:918-929.
78. Perry H.B., Zulliger R., Rogers M.M. Community health workers in low-, middle-, and high-income countries: an overview of their history, recent evolution, and current effectiveness. Annu Rev Public Health 2014, 35:399-421.
79. Joshi R., Chow C.K., Raju P.K., et al. The Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS). J Am Coll Cardiol 2012, 59:1188-1196.
80. Kengne A., Awah P.K., Fezeu L.L., Sobngwi E., Mbanya J.C. Primary health care for hypertension by nurses in rural and urban Sub-Saharan Africa. J Clin Hypertens (Greenwich) 2009, 11:564-572.
81. Adeyemo A., Tayo B.O., Luke A., et al. The Nigerian antihypertensive adherence trial: a community-based randomized trial. J Hypertens 2013, 31:201-207.
82. Ogedegbe G., Gyamfi J., Plange-Rhule J., et al. Task shifting interventions for cardiovascular risk reduction in low-income and middle-income countries: a systematic review of randomised controlled trials. BMJ Open 2014, 4:e005983.
83. Becker D., Yanek L.R., et al. Impact of a community-based multiple risk factor intervention on cardiovascular risk in black families with a history of premature coronary disease. Circulation 2005, 111:1298-1304.
84. Brownstein J.N., Chowdhury F.M., Norris S.L., et al. Effectiveness of community health workers in the care of people with hypertension. Am J Prev Med 2007, 32:435-447.
85. One Million Health Workers Campaign. Available at:. Accessed January 15, 2015. http://www.1millionhealthworkers.org.
86. Beratarrechea A., Lee A.G., Willner J.M., et al. The impact of mobile health interventions on chronic disease outcomes in developing countries: a systematic review. Telemed JE Health 2014, 20:75-82.
87. Lester R.T., Ritvo P., Mills E.J., et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet 2010, 376:1838-1845.
88. Pop-Eleches C., Thirumurthy H., Habyarimana J.P., et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS 2011, 25:825-834.
89. Shetty A.S., Chamukuttan S., Nanditha A., Raj R.K., Ramachandran A. Reinforcement of adherence to prescription recommendations in Asian Indian diabetes patients using short message service (SMS)-a pilot study. J Assoc Physicians India 2011, 59:711-714.
90. Peiris D., Devarsetty P., Claire J., Mogulluru K. Use of mHealth systems and tools for non-communicable diseases in low- and middle-income countries: a systematic review. J Cardiovasc Transl Res 2014, 7:677-691.